UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review

Gastroenterology (New York, N.Y. 1943), 2021-02, Vol.160 (3), p.912-918

2021

Volltextzugriff (PDF)

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries

The American journal of gastroenterology, 2017-01, Vol.112 (1), p.18-35

2017

Volltextzugriff (PDF)

AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor Colitis and Hepatitis: Expert Review

Gastroenterology (New York, N.Y. 1943), 2021-03, Vol.160 (4), p.1384-1393

2021

Volltextzugriff (PDF)

Emerging trends in hepatocellular carcinoma incidence and mortality

Hepatology (Baltimore, Md.), 2015-01, Vol.61 (1), p.191-199

2015

Volltextzugriff (PDF)

AGA Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic

Gastroenterology (New York, N.Y. 1943), 2020-08, Vol.159 (2), p.739-758.e4

2020

Volltextzugriff (PDF)

Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges

Gastroenterology (New York, N.Y. 1943), 2019-01, Vol.156 (2), p.431-445

2019

Volltextzugriff (PDF)

AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review

Gastroenterology (New York, N.Y. 1943), 2019-06, Vol.156 (8), p.2149-2157

2019

Volltextzugriff (PDF)

American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy

Gastroenterology (New York, N.Y. 1943), 2015, Vol.148 (1), p.215-219

2015

Volltextzugriff (PDF)

Prevalence of Chronic Hepatitis B Virus Infection in the United States

The American journal of gastroenterology, 2020-09, Vol.115 (9), p.1429-1438

2020

Volltextzugriff (PDF)

American Gastroenterological Association Institute Clinical Practice Update—Expert Review: Care of Patients Who Have Achieved a Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C Infection

Gastroenterology (New York, N.Y. 1943), 2017-05, Vol.152 (6), p.1578-1587

2017

Volltextzugriff (PDF)

DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort

Journal of hepatology, 2020-09, Vol.73 (3), p.540-548

2020

Volltextzugriff (PDF)

Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease

World journal of gastroenterology : WJG, 2016-10, Vol.22 (37), p.8294-8303

2016

Volltextzugriff (PDF)

Reduced functional segregation between the default mode network and the executive control network in healthy older adults: A longitudinal study

NeuroImage (Orlando, Fla.), 2016-06, Vol.133, p.321-330

2016

Volltextzugriff (PDF)

American Gastroenterological Association Institute Guideline on the Role of Elastography in the Evaluation of Liver Fibrosis

Gastroenterology (New York, N.Y. 1943), 2017-05, Vol.152 (6), p.1536-1543

2017

Volltextzugriff (PDF)

An explainable machine learning model for prediction of high-risk nonalcoholic steatohepatitis

Scientific reports, 2024-04, Vol.14 (1), p.8589-8589, Article 8589

2024

Volltextzugriff (PDF)

Outcomes of a 1-Year Pilot Study Implementing Universal Hepatitis Delta Virus Testing Among Veterans With Chronic Hepatitis B

Journal of viral hepatitis, 2024-08

2024

Volltextzugriff (PDF)

Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study

Gut, 2017-10, Vol.66 (10), p.1844-1852

2017

Volltextzugriff (PDF)

Drug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care Cascade

PloS one, 2015-08, Vol.10 (8), p.e0135645-e0135645

2015

Volltextzugriff (PDF)

AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review

Gastroenterology (New York, N.Y. 1943), 2022-09, Vol.163 (3), p.764-774.e1

2022

Volltextzugriff (PDF)

Safety profile of boceprevir and telaprevir in chronic hepatitis C: Real world experience from HCV-TARGET

Journal of hepatology, 2015-02, Vol.62 (2), p.286-293

2015

Volltextzugriff (PDF)

Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case–control study

Cancer causes & control, 2020-04, Vol.31 (4), p.321-332

2020

Volltextzugriff (PDF)

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries

The American journal of gastroenterology, 2017-01, Vol.112 (1), p.18-35

2017

Volltextzugriff (PDF)

Simplifying the Diagnosis and Treatment of Hepatitis B Infection: One Step for Addressing Deficits in the Care Cascade, One Leap for Elimination

Gastro hep advances, 2023, Vol.2 (2), p.277-278

2023

Volltextzugriff (PDF)

AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.1822-1830

2020

Volltextzugriff (PDF)

1 – 25 von 817

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(724)
Mit Volltextzugriff
(674)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(810)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(522)
Life Sciences & Biomedicine
(450)
Humans
(397)
Female
(213)
Male
(203)
Adult
(137)
Middle Aged
(136)
Gastroenterology & Hepatology
(131)
Aged
(91)
Biological And Medical Sciences
(76)
Patients
(66)
Medical Sciences
(63)
Treatment Outcome
(62)
Gastroenterology And Hepatology
(61)
Hepatitis C
(57)
Risk Factors
(56)
Animals
(52)
Adolescent
(51)
General & Internal Medicine
(51)
Science & Technology - Other Topics
(50)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries

AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor Colitis and Hepatitis: Expert Review

Emerging trends in hepatocellular carcinoma incidence and mortality

AGA Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic

Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges

AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review

American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy

Prevalence of Chronic Hepatitis B Virus Infection in the United States

American Gastroenterological Association Institute Clinical Practice Update—Expert Review: Care of Patients Who Have Achieved a Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C Infection

DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort

Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease

Reduced functional segregation between the default mode network and the executive control network in healthy older adults: A longitudinal study

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study

American Gastroenterological Association Institute Guideline on the Role of Elastography in the Evaluation of Liver Fibrosis

An explainable machine learning model for prediction of high-risk nonalcoholic steatohepatitis

Outcomes of a 1-Year Pilot Study Implementing Universal Hepatitis Delta Virus Testing Among Veterans With Chronic Hepatitis B

Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study

Drug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care Cascade

AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review

Safety profile of boceprevir and telaprevir in chronic hepatitis C: Real world experience from HCV-TARGET

Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case–control study

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries

Simplifying the Diagnosis and Treatment of Hepatitis B Infection: One Step for Addressing Deficits in the Care Cascade, One Leap for Elimination

AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review

Suchergebnisse filtern